Literature DB >> 25586598

Prediction models of Medicare 90-day postdischarge deaths, readmissions, and costs in bowel operations.

Donald E Fry1, Michael Pine2, David Locke2, Gregory Pine2.   

Abstract

BACKGROUND: The 90-day postdischarge morbidity and mortality rates following elective and emergent bowel surgery remain poorly defined.
METHODS: The 2009 to 2011 Medicare inpatient files for patients undergoing elective and emergent small and large bowel operations in 1,024 hospitals that passed present-on-admission coding accuracy standards had prediction models designed for inpatient mortality, prolonged postoperative length of hospital stay (prLOS), 90-day postdischarge mortality and readmissions, and total hospital costs.
RESULTS: Of 118,758 patients studied, there was a 4.7% inpatient mortality rate and 7.3% prLOS among live discharges. An additional 7,586 deaths and 26,969 readmissions occurred within 90 days of discharge. Prolonged preoperative and prolonged postoperative hospitalizations were significant (P < .0001) variables in predicting postdischarge deaths and readmissions. Total hospital costs were increased by over $18,000 per adverse outcome.
CONCLUSION: Postdischarge deaths and readmissions are more common than inpatient adverse events of death and prLOS in elective and emergent Medicare large and small bowel operations.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Control charts; Large bowel surgery; Postdischarge deaths; Postdischarge readmissions; Risk-adjusted outcomes; Small bowel surgery

Mesh:

Year:  2014        PMID: 25586598     DOI: 10.1016/j.amjsurg.2014.12.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes.

Authors:  Michael D George; Joshua F Baker; Kevin Winthrop; Evo Alemao; Lang Chen; Sean Connolly; Jesse Y Hsu; Teresa A Simon; Qufei Wu; Fenglong Xie; Shuo Yang; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-11       Impact factor: 4.794

Review 2.  Infection control in colon surgery.

Authors:  Donald E Fry
Journal:  Langenbecks Arch Surg       Date:  2016-06-27       Impact factor: 3.445

3.  Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study.

Authors:  Michael D George; Joshua F Baker; Kevin Winthrop; Evo Alemao; Lang Chen; Sean Connolly; Jesse Y Hsu; Teresa A Simon; Qufei Wu; Fenglong Xie; Shuo Yang; Jeffrey R Curtis
Journal:  Ann Intern Med       Date:  2019-05-21       Impact factor: 25.391

4.  Older Age and Leg Pain Are Good Predictors of Pain and Disability Outcomes in 2710 Patients Who Receive Lumbar Fusion.

Authors:  Chad E Cook; Anthony K Frempong-Boadu; Kristen Radcliff; Isaac Karikari; Robert Isaacs
Journal:  HSS J       Date:  2015-08-05

5.  Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty.

Authors:  Michael D George; Joshua F Baker; Jesse Yenchih Hsu; Qufei Wu; Fenglong Xie; Lang Chen; Huifeng Yun; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-02       Impact factor: 4.794

6.  Discharge to the skilled nursing facility: patient risk factors and perioperative outcomes after total knee arthroplasty.

Authors:  Prem N Ramkumar; Chukwuweike Gwam; Sergio M Navarro; Heather S Haeberle; Jaret M Karnuta; Ronald E Delanois; Michael A Mont
Journal:  Ann Transl Med       Date:  2019-02

7.  Risk-adjusted outcomes in Medicare inpatient nephrectomy patients.

Authors:  Donald E Fry; Michael Pine; Susan M Nedza; David G Locke; Agnes M Reband; Gregory Pine
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Risk-adjusted outcomes of inpatient medicare medical admissions.

Authors:  Donald E Fry; Susan M Nedza; Michael Pine; Agnes M Reband; Chun-Jung Huang; Gregory Pine
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.